Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate.

about

Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate.

Item

http://www.wikidata.org/entity/Q46091753

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Demonstration of Biological an ...... a Generic Glatiramer Acetate.

@en

Demonstration of Biological an ...... a Generic Glatiramer Acetate.

@nl

type

Item

label

Demonstration of Biological an ...... a Generic Glatiramer Acetate.

@en

Demonstration of Biological an ...... a Generic Glatiramer Acetate.

@nl

prefLabel

Demonstration of Biological an ...... a Generic Glatiramer Acetate.

@en

Demonstration of Biological an ...... a Generic Glatiramer Acetate.

@nl

P1476

Demonstration of Biological an ...... a Generic Glatiramer Acetate.

@en

P2093

Christopher Honan

http://www.w3.org/2001/XMLSchema#string

Daniel Kantor

http://www.w3.org/2001/XMLSchema#string

Ganesh Kaundinya

http://www.w3.org/2001/XMLSchema#string

Ganlin Zhao

http://www.w3.org/2001/XMLSchema#string

Ian Fier

http://www.w3.org/2001/XMLSchema#string

Ishan Capila

http://www.w3.org/2001/XMLSchema#string

Jay Duffner

http://www.w3.org/2001/XMLSchema#string

Josephine D Alessandro

http://www.w3.org/2001/XMLSchema#string

Kevin Garofalo

http://www.w3.org/2001/XMLSchema#string

Tanmoy Ganguly

http://www.w3.org/2001/XMLSchema#string

P2860

Demonstration of equivalence of a generic glatiramer acetate (Glatopa™)

Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications

Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action

Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

P304

714-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1871527316666170223162747

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28240190

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

5684786

http://www.w3.org/2001/XMLSchema#string